Hypertension, left ventricular hypertrophy and chronic kidney disease. - Wikidata - awgldk - TriplyDB

Hypertension, left ventricular hypertrophy and chronic kidney disease.

Hypertension, left ventricular hypertrophy and chronic kidney disease.

http://www.wikidata.org/entity/Q37813472

about

Lipids, blood pressure and kidney update 2015 Myocardial hypertrophy and its role in heart failure with preserved ejection fraction Arterial stiffness, central pressures, and incident hospitalized heart failure in the chronic renal insufficiency cohort study The relation between serum phosphorus levels and clinical outcomes after acute myocardial infarction Implications of Klotho in vascular health and disease.Serum uric acid is associated with left ventricular hypertrophy independent of serum parathyroid hormone in male cardiac patients.New-onset diabetes and glucose regulation are significant determinants of left ventricular hypertrophy in renal transplant recipients.Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.High-Dose Menaquinone-7 Supplementation Reduces Cardiovascular Calcification in a Murine Model of Extraosseous Calcification.Association of base excision repair gene polymorphisms with ESRD risk in a Chinese population Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart.Epidemiology and importance of renal dysfunction in heart failure patients.The vulnerable patient with chronic kidney disease.Should chronic metabolic acidosis be treated in older people with chronic kidney disease?Factors associated with cardiovascular target organ damage in children after renal transplantation.αKlotho and Chronic Kidney Disease.The Impact on Central Blood Pressure and Arterial Stiffness Post Renal Denervation in Patients With Stage 3 and 4 Chronic Kidney Disease: The Prairie Renal Denervation Study.Hyperuricemia is independently associated with left ventricular hypertrophy in post-menopausal women but not in pre-menopausal women in rural Northeast China.New Insights into the Mechanism of Action of Soluble Klotho.Impact of hemodialysis, left ventricular mass and FGF-23 on myocardial mechanics in end-stage renal disease: a three-dimensional speckle tracking study.The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study.The role of mitofilin in left ventricular hypertrophy in hemodialysis patients.Deterioration of Deceleration Capacity of Heart Rate is Associated with Left Ventricular Hypertrophy in End-Stage Renal Disease Population.

P2860

Q26771550-2B77823E-FDE0-46EB-8678-71879D4C1CDF Q26800076-CC91F6E1-AAA4-43B7-97B6-A924AEE4525B Q34207275-77229B1E-BFD2-4435-993A-2A7CA8FE8909 Q34625745-C6449520-6A01-4D16-9E80-D5767E67BF88 Q34780123-CA4C17F4-6A9D-4AAE-9EA2-2740160BB3C0 Q35067870-511A3DF5-DFEE-44CA-9752-242162CEDBF8 Q35508630-6EFA165E-7F13-42FC-A22D-EBDBC4B7E700 Q35550609-792FD067-0638-42EB-90E4-8CE203E3142B Q35752060-091FA9CC-2D0B-416C-B3FB-F272A8FCA703 Q36031812-50B03227-86E8-4DF2-9498-C11D9EEC98BF Q36479676-D80CDD87-9774-4AEC-A4D5-DCECF6CB2A90 Q38149800-086538FA-CF07-4E1C-B1F7-6735C3357D73 Q38368207-1D7332DC-25B2-4D01-AC84-3FF70E5014AF Q38595572-322E4BD4-F2ED-4711-A280-99CA9F890E56 Q38626501-1498C94C-3363-4E90-9F9D-F3C389891646 Q39812781-5A01D0C3-2BAA-4CEA-AC12-E855B9BD4544 Q41137254-D5BB4BBD-306B-4BDE-8CF8-68EF506168FB Q41351149-A0F8D3F7-3410-4A11-8C35-C9A4D9173B7B Q47132894-9AFA697D-BD61-4302-88FC-A1B8F8D392CF Q50613899-F2123378-B702-4015-AA19-38ADFBDC963B Q51765638-591429B8-49FE-42C8-B7F1-9785B78664E8 Q52605495-1C765834-B660-4F1F-B0C6-877B5DE6C75D Q55449857-AC9693BB-8006-4509-BFF2-9C15B0F9AEBA

P2860

Hypertension, left ventricular hypertrophy and chronic kidney disease.

http://www.wikidata.org/entity/Q37813472

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Hypertension, left ventricular hypertrophy and chronic kidney disease.

@en

Hypertension, left ventricular hypertrophy and chronic kidney disease.

@nl

type

label

Hypertension, left ventricular hypertrophy and chronic kidney disease.

@en

Hypertension, left ventricular hypertrophy and chronic kidney disease.

@nl

prefLabel

Hypertension, left ventricular hypertrophy and chronic kidney disease.

@en

Hypertension, left ventricular hypertrophy and chronic kidney disease.

@nl

P1433

Q37813472-0ADCC331-E030-4511-B697-C37B59E704C3

P1476

Q37813472-2E2210F8-0899-4577-BEA9-83FD5AAF3E08

P2093

Q37813472-1F13F43A-2EF5-48B8-8A8A-5ADF08A6C64B

Q37813472-595F5309-8F7F-4635-A74A-037077393788

Q37813472-68AB1E96-504B-41BA-8569-60589F02B0E9

Q37813472-CFB083C0-D475-4D8B-AA38-321B7B60B3AE

P2860

Q37813472-01A3D936-B99F-47B0-AB01-246BA7C6ED84

Q37813472-01D502E9-ED23-4E18-8592-FECC4964F7C7

Q37813472-03F289F9-2DE2-48F1-BE61-8F579D15831A

Q37813472-07701B44-E18E-4F07-8E8F-6C9A17143FE1

Q37813472-0B9AE01A-8007-45CD-B501-4A82282A4657

Q37813472-1BC5BA54-B55D-4955-AF6C-416F33667D1A

Q37813472-1C29DDDF-04D7-4A75-A84C-8DE1BB6327AC

Q37813472-2AE5C022-B336-4C43-AB39-F2470DD18AFC

Q37813472-2B0FA240-D851-49E5-B6BB-B5A8E6DC34CE

Q37813472-2D1E30B5-6286-4E86-9F37-A03A740558B2

P2888

Q37813472-6586CB5D-2834-4E79-AF03-275170B06B87

P304

Q37813472-552A35CF-69B8-4E09-A6F2-C6222301724F

P31

Q37813472-CCCB749B-E93E-4F62-954A-B1F12A440AAB

Q37813472-b3319db9-842b-4829-9748-84791dbeab25

P356

Q37813472-CF7BAB5C-7EAF-491A-92F0-9C5B1EAC2178

P433

Q37813472-048771E4-80F0-4A6B-AE96-6D6D776219A1

P478

Q37813472-00C79F94-2592-470E-ACEE-5EEC3C28D7DB

P50

Q37813472-8A306CC4-1808-4E9A-A3A3-CF7C59AF42D4

P577

Q37813472-F0325C16-8DF9-4015-BE59-18F438ECE619

P698

Q37813472-C33E177D-35C3-4677-A5FE-E200D433AB3C

P921

Q37813472-41FDEFC6-A2A8-45DC-B064-F85453EDF714

P356

S10741-010-9197-Z

P1433

Heart Failure Reviews

P1476

Hypertension, left ventricular hypertrophy and chronic kidney disease.

@en

P2093

Ilaria Quatrini

http://www.w3.org/2001/XMLSchema#string

Ranuccio Nuti

http://www.w3.org/2001/XMLSchema#string

Renato Nami

http://www.w3.org/2001/XMLSchema#string

Stefano Taddei

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension.

Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure.

Signaling pathways for cardiac hypertrophy and failure.

Pathophysiology of anaemia: focus on the heart and blood vessels.

Arterial elastance and wave reflection augmentation of systolic blood pressure: deleterious effects and implications for therapy.

Left ventricular alterations and end-stage renal disease.

Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.

Anemia in chronic kidney disease and congestive heart failure.

P2888

s10741-010-9197-z

P304

615-620

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10741-010-9197-Z

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Rosa Maria Bruno

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21116711

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension